Poor glycemic control, oxidative stress, and low-grade inflammation are putative mechanisms linking type 1 and type 2 diabetes to increased cardiovascular disease risk.
This review highlights the complex interplay of hyperglycemia, oxidative stress, inflammation, and epigenetics in driving cardiovascular disease among patients with diabetes.
Cardiovascular diseases are the most prevalent cause of morbidity and mortality among patients with type 1 or type 2 diabetes. The proposed mechanisms that can link accelerated atherosclerosis and increased cardiovascular risk in this population are poorly understood. It has been suggested that an association between hyperglycemia and intracellular metabolic changes can result in oxidative stress, low-grade inflammation, and endothelial dysfunction. Recently, epigenetic factors by different types of reactions are known to be responsible for the interaction between genes and environment and for this reason can also account for the association between diabetes and cardiovascular disease. The impact of clinical factors that may coexist with diabetes such as obesity, dyslipidemia, and hypertension are also discussed. Furthermore, evidence that justify screening for subclinical atherosclerosis in asymptomatic patients is controversial and is also matter of this review. The purpose of this paper is to describe the association between poor glycemic control, oxidative stress, markers of insulin resistance, and of low-grade inflammation that have been suggested as putative factors linking diabetes and cardiovascular disease.
Matheus et al. (Tue,) conducted a review in Type 1 or type 2 diabetes and cardiovascular disease. Poor glycemic control, oxidative stress, and low-grade inflammation are putative mechanisms linking type 1 and type 2 diabetes to increased cardiovascular disease risk.